Profile image
Story Views

Last Hour:
Last 24 Hours:

Pulmonary Arterial Hypertension (PAH) – Market Insights, Epidemiology and Market Size Forecast-2020

Sunday, February 26, 2017 22:53
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher’s “Pulmonary Arterial Hypertension (PAH) – Market Insights, Epidemiology and Market Size Forecast-2020″ Reports provides an overview of the disease and global market size of the Pulmonary Arterial Hypertension (PAH) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Pulmonary Arterial Hypertension (PAH) from 2010-2020.Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. About 50 percent of people who have been diagnosed with PAH will die from the disease within five years. Treatment can extend life expectancy, but people diagnosed with PAH who don’t receive adequate treatment live an average of three years. It is expected that in the near future some of these potential therapeutic options can be utilized in combination with established pharmacologic therapies to treat PAH aggressively by targeting multiple effectors pathways, thereby offering both symptomatic and survival benefits to the sufferers of this progressively fatal disease.

For more information about this report:


- Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.

- It also provides Market size of Pulmonary Arterial Hypertension (PAH) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020


Table of Contents

- Pulmonary Arterial Hypertension (PAH)

- Disease overview:

- Pathophysiology:

- Symptoms of disease:

- Etiology of disease

- Diagnosis of disease

- Treatment of disease

- Overview of Marketed drugs

- Drug Description

Request Sample Copy at

- Mechanism of Action
- Pharmacokinetics Properties
- Marketed Details
- United States
- Patent Information
- Patent Exclusivity Expiry Assessment United States (US)
- Patents Details
- Historical and Forecasted sales of marketed molecules in the Global Pulmonary Arterial Hypertension (PAH) Market
- Global Epidemiology of Pulmonary Arterial Hypertension (PAH) Forecasted to 2020
- Global Market size (2011-2014)
- Global Forecasted Market size (2015-2020)
- Global Market Size by Geography
- Market size of US (2011-2014)
- Forecasted Market size of US (2015-2020)
- Market size of Europe
- Market size of Germany (2011-2014)
- Forecasted Market size of Germany (2015-2020)
- Market size of United Kingdom (2011-2014)
- Forecasted Market size of United Kingdom (2015-2020)
- Market size of France (2011-2014)
- Forecasted Market size of France (2015-2020)
- Market size of Italy (2011-2014)
- Forecasted Market size of Italy (2015-2020)
- Market size of Spain (2011-2014)
- Forecasted Market size of Spain (2015-2020)
- Market size of Japan (2011-2014)
- Forecasted Market Size of Japan (2015-2020)
- Market size of ROW (2011-2014)
- Forecasted Market size of ROW (2015-2020)
- Appendix
- Report Methodology

Inquire before Buying at

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.